» Articles » PMID: 2191712

A Comparison of Local and Systemic Acyclovir in the Management of Herpetic Disciform Keratitis

Overview
Journal Br J Ophthalmol
Specialty Ophthalmology
Date 1990 May 1
PMID 2191712
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Forty-three patients with active herpetic disciform keratitis were entered into an open study to compare the efficacy of oral acyclovir (400 mg) with acyclovir ophthalmic ointment (3%) to inhibit viral replication during treatment with 0.05% prednisolone eye drops. All patients, regardless of the mode of therapy, were treated five times a day until they were healed. The mean time to heal in the oral group was 25.9 days and in the topical group was 25.3 days. Resolution of lacrimation was significantly faster in the oral group (12.1 days versus 27.6 days). The patients on tablets also showed a greater improvement in visual acuity. No statistically significant differences were found between the two groups in the incidence of recurrences over a three-year post-treatment period. It is concluded that oral acyclovir treatment is an effective alternative to ophthalmic ointment in the management of herpetic disciform keratitis.

Citing Articles

Steroids in the Management of Infectious Keratitis.

Keenan J Cornea. 2023; 42(11):1333-1339.

PMID: 38112645 PMC: 10730951. DOI: 10.1097/ICO.0000000000003340.


Adoption of Innovation in Herpes Simplex Virus Keratitis.

Chodosh J, Ung L Cornea. 2020; 39 Suppl 1:S7-S18.

PMID: 32732703 PMC: 7664964. DOI: 10.1097/ICO.0000000000002425.


MicroRNAs in Ocular Infection.

Xu S, Hazlett L Microorganisms. 2019; 7(9).

PMID: 31533211 PMC: 6780979. DOI: 10.3390/microorganisms7090359.


A stepping stone in treating dendritic keratitis.

Sheha H, Tighe S, Cheng A, Tseng S Am J Ophthalmol Case Rep. 2017; 7:55-58.

PMID: 29260079 PMC: 5722148. DOI: 10.1016/j.ajoc.2017.06.002.


Herpes keratitis.

Rowe A, St Leger A, Jeon S, Dhaliwal D, Knickelbein J, Hendricks R Prog Retin Eye Res. 2012; 32:88-101.

PMID: 22944008 PMC: 3529813. DOI: 10.1016/j.preteyeres.2012.08.002.


References
1.
Crumpacker C, Schnipper L, Zaia J, Levin M . Growth inhibition by acycloguanosine of herpesviruses isolated from human infections. Antimicrob Agents Chemother. 1979; 15(5):642-5. PMC: 352730. DOI: 10.1128/AAC.15.5.642. View

2.
De Clercq E, Descamps J, Verhelst G, Walker R, Jones A, Torrence P . Comparative efficacy of antiherpes drugs against different strains of herpes simplex virus. J Infect Dis. 1980; 141(5):563-74. DOI: 10.1093/infdis/141.5.563. View

3.
Young B, Patterson A, Ravenscroft T . A randomised double-blind clinical trial of acyclovir (Zovirax) and adenine arabinoside in herpes simplex corneal ulceration. Br J Ophthalmol. 1982; 66(6):361-3. PMC: 1039800. DOI: 10.1136/bjo.66.6.361. View

4.
Collum L, Grant D . A double-blind comparative trial of acyclovir and adenine arabinoside in combination with dilute betamethasone in the management of herpetic disciform keratitis. Curr Eye Res. 1987; 6(1):221-4. DOI: 10.3109/02713688709020094. View

5.
Collum L, Logan P, Ravenscroft T . Acyclovir (Zovirax) in herpetic disciform keratitis. Br J Ophthalmol. 1983; 67(2):115-8. PMC: 1039978. DOI: 10.1136/bjo.67.2.115. View